US 7208600
Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
granted A61KA61K38/08A61P
Quick answer
US patent 7208600 (Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/08, A61P, A61P1/16, A61P31/12